Edition:
United States

Rhythm Pharmaceuticals Inc (RYTM.OQ)

RYTM.OQ on NASDAQ Stock Exchange Global Market

30.40USD
10:44am EDT
Change (% chg)

$-0.07 (-0.23%)
Prev Close
$30.47
Open
$30.66
Day's High
$31.15
Day's Low
$30.34
Volume
9,847
Avg. Vol
76,475
52-wk High
$37.23
52-wk Low
$16.89

Chart for

About

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. The Company’s lead peptide product candidate is setmelanotide, a potent,... (more)

Overall

Beta: --
Market Cap(Mil.): $1,041.32
Shares Outstanding(Mil.): 34.18
Dividend: --
Yield (%): --

Financials

  RYTM.OQ Industry Sector
P/E (TTM): -- 103.50 32.14
EPS (TTM): -1.97 -- --
ROI: -32.08 1.52 12.66
ROE: -33.07 0.25 14.84

BRIEF-Rhythm Pharmaceuticals Q1 Loss Per Share $0.60

* RHYTHM PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 14 2018

BRIEF-Rhythm Pharma Announces Licensing Agreement With Takeda

* RHYTHM PHARMACEUTICALS ANNOUNCES LICENSING AGREEMENT WITH TAKEDA FOR THE DEVELOPMENT AND COMMERCIALIZATION OF PRECLINICAL TREATMENT FOR PRADER-WILLI SYNDROME

Apr 02 2018

Earnings vs. Estimates